Europe Rejects Cinainu (Alopecia) & Kizfizo (Neuroblastoma)
Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended refusal of marketing authorizations for: Cinainu (allium/citrus/Paullinia/cacao), an herbal medicine intended to treat moderate to severe alopecia areata in children and adolescents Kizfizo (temozolomide) for the treatment of neuroblastoma in children older than 1 year Herbal Extracts Cinainu contains herbal extracts of onion…
Read More
0
